Colorectal cancer (CRC) can be classified as high-level microsatellite instability (MSI-H), low-level MSI (MSI-L) and microsatellite stable (MSS) depending on levels of MSI. MSI-H CRC relies on a distinct molecular pathway due to the mismatch repair (MMR) deficiency and shows methylation in multiple gene promoters. The genetic pathway leading to MSI-L is unknown, although higher levels of promoter methylation are observed in this group compared with MSS CRCs. This study explored how promoter methylation affects MSI phenotype, by analysing the methylation status of eight CRC-related promoters, MSI phenotype and KRAS/BRAF mutations in a series of 234 CRCs. Promoter methylation of p14ARF was significantly related to MSI-L CRC with KRAS mutation. The MSI-H phenotype was related to methylation of MLH1 as expected, while the MSS phenotype was related to methylation of p16INK4a and O6-methylguanine-DNA methyltransferase, although this was not statistically significant. Thus, promoter methylation of p14ARF could be a significant alteration leading to CRC with MSI-L.
PeltomakiPLotheRAAaltonenLA: Microsatellite instability is associated with tumors that characterize the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer Res1993; 53: 5853–5855.
2.
YoungJSimmsLABidenKG: Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: Parallel pathways of tumorigenesis. Am J Pathol2001; 159: 2107–2116.
3.
CunninghamJMChristensenERTesterDJ: Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res1998; 58: 3455–3460.
4.
BolandCRThibodeauSNHamiltonSR: A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res1998; 58: 5248–5257.
5.
JassJRBidenKGCummingsMC: Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol1999; 52: 455–460.
6.
WatsonPLinKMBigasMA Rodriguez: Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer1998; 83: 259–266.
7.
TomlinsonIHalfordSAaltonenL: Does MSI-low exist?J Pathol2002; 197: 6–13.
8.
ThibodeauSNFrenchAJCunninghamJM: Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1. Cancer Res1998; 58: 1713–1718.
9.
UmarABolandCRTerdimanJP: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst2004; 96: 261–268.
10.
HalfordSSasieniPRowanA: Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. Cancer Res2002; 62: 53–57.
11.
LaihoPLaunonenVLahermoP: Low-level microsatellite instability in most colorectal carcinomas. Cancer Res2002; 62: 1166–1170.
12.
MoriYSelaruFMSatoF: The impact of microsatellite instability on the molecular phenotype of colorectal tumors. Cancer Res2003; 63: 4577–4582.
13.
KambaraTMatsubaraNNakagawaH: High frequency of low-level microsatellite instability in early colorectal cancer. Cancer Res2001; 61: 7743–7746.
14.
NagasakaTSasamotoHNotoharaK: Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol2004; 22: 4584–4594.
15.
DukesCE: The classification of cancer of the rectum. J Path Bact1932; 35: 323–332.
16.
BlinNStaffordDW: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res1976; 3: 2303–2308.
17.
KahnSMJiangWCulbertsonTA: Rapid and sensitive nonradioactive detection of mutant K-ras genes via ‘enriched’ PCR amplification. Oncogene1991; 6: 1079–1083.
18.
XiongZLairdPW: COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res1997; 25: 2532–2534.
19.
RashidAShenLMorrisJS: CpG island methylation in colorectal adenomas. Am J Pathol2001; 159: 1129–1135.
20.
ShenLKondoYHamiltonSR: P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. Gastroenterology2003; 124: 626–633.
21.
ToyotaMAhujaNOhe-ToyotaM: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA1999; 96: 8681–8686.
22.
JassJRBakerKZlobecI: Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: Concept of a ‘fusion’ pathway to colorectal cancer. Histopathology2006; 49: 121–131.
23.
KinzlerKWVogelsteinB: Lessons from hereditary colorectal cancer. Cell1996; 87: 159–170.
24.
JassJR: Hyperplastic polyps and colorectal cancer: Is there a link?Clin Gastroenterol Hepatol2004; 2: 1–8.
25.
TorlakovicESkovlundESnoverDC: Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol2003; 27: 65–81.
26.
KambaraTSimmsLAWhitehallVL: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut2004; 53: 1137–1144.
27.
YangSFarrayeFAMackC: BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: Relationship to histology and CpG island methylation status. Am J Surg Pathol2004; 28: 1452–1459.
28.
RosenbergDWYangSPleauDC: Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res2007; 67: 3551–3554.
29.
O'BrienMJYangSClebanoffJL: Hyperplastic (serrated) polyps of the colorectum: Relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol2004; 28: 423–434.
30.
GazinCWajapeyeeNGobeilS: An elaborate pathway required for Ras-mediated epigenetic silencing. Nature2007; 449: 1073–1077.
31.
EstellerMToyotaMCespedesM Sanchez: Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res2000; 60: 2368–2371.
32.
EstellerMRisquesRAToyotaM: Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res2001; 61: 4689–4692.
33.
ZhangYXiongYYarbroughWG: ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell1998; 92: 725–734.
34.
PomerantzJSchreiber-AgusNLiegeoisNJ: The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell1998; 92: 713–723.
